Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors

Kaori Matsumoto, Tatsuo Kanda, Junichiro Wakatsuki, Young‐Jin Kim, Ritsuko Yokouchi, Naho Sato, Yūko Hasegawa, Kenji Amemiya, Yosuke Hirotsu, Sumio Hirose, Yushi Imai, Shinya Takaoka, Hiroyuki Amano, Yukiko Asakawa, Kouwa Nagasaka, Yoshiki Asahina, Yuichiro Kojima, Shodai Toyama, Hitoshi Mochizuki, Shuntaro Obi, Masao Omata